The present invention relates to a methods for producing bio-oils from vegetation high in lignin. The invention further relates to antimicrobial compositions comprising bio-oil extracted from vegetation high in lignin.

The present invention relates to a methods for producing bio-oils from vegetation high in lignin. The invention further relates to antimicrobial compositions comprising bio-oil extracted from vegetation high in lignin.

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.

The present invention pertains to the use for preventing or treating intestinal infections caused by gram-positive bacteria in animals of an antibacterial compound selected from lactylate in accordance with formula 1,
R2—COO—[—CH(CH.sub.3)—COO].sub.n—R1  Formula 1
or a Na, K, Ca, Mg, Fe(II), Zn, NH.sub.4, or Cu(II) salt thereof, a glycolylate of formula 2,
R2—COO—[—CH2—COO].sub.n—R1  Formula 2
or a Na, K, Ca, Mg, Fe(II), Zn, NH.sub.4, or Cu(II) salt thereof, a lactate ester of formula 3,
HO—CH(CH.sub.3)—COO—R22  Formula 3
and/or a glycolic acid ester of formula 4,
HO—CH2—COO—R2  Formula 4
wherein R1 is selected from H, n stands for an integer with a value of 1-10, and R2 stands for a C1-C35 alkyl or alkenyl chain which may be branched or unbranched. The compound, which preferably is a lactylate or a Na, K, Ca, Mg, Fe(II), Zn, NH.sub.4, or Cu(II) salt thereof, is particularly useful in the treatment or prevention of Clostridia. An animal nutrition composition and a method for preventing or treating infections are also claimed.

A method for making a dental appliance configured to position at least one tooth of a patient includes printing a hardenable liquid resin composition on a major surface of a polymeric material to form a pattern of discrete unhardened liquid regions thereon; at least partially hardening the unhardened liquid regions to form a corresponding array of structures on the major surface of the polymeric material, wherein the structures have a characteristic cross-sectional dimension of about 25 microns to about 1 mm, and a feature spacing of about 100 microns to about 2000 microns; and forming a plurality of cavities in the polymeric material to form the dental appliance including an arrangement of cavities configured to receive one or more teeth.

A method for making a dental appliance configured to position at least one tooth of a patient includes printing a hardenable liquid resin composition on a major surface of a polymeric material to form a pattern of discrete unhardened liquid regions thereon; at least partially hardening the unhardened liquid regions to form a corresponding array of structures on the major surface of the polymeric material, wherein the structures have a characteristic cross-sectional dimension of about 25 microns to about 1 mm, and a feature spacing of about 100 microns to about 2000 microns; and forming a plurality of cavities in the polymeric material to form the dental appliance including an arrangement of cavities configured to receive one or more teeth.

This invention refers to a pharmaceutical composition that comprises the synergic combination of a NSAID, such as the active ingredient: S-ketorolac of tromethamine and a GABA derivative agent, such as the active ingredient: gabapentin, which are formulated with pharmaceutically acceptable excipients in a single dosing unit to be administered by oral, parenteral, topical, transdermal means or with the use of transdermal, oral or nasal inhalation devices, which is indicated for the treatment of neuropathic and/or nociceptive pain caused by different etiologies.

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical and/or personal care products and applications.